Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole - Fasching, P A; Hack, C C; Nabieva, N (Eur J Cancer, 2024)